1 One Year Post Exclusivity Adverse Event Review: Topotecan Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee Meeting June 9, 2004.
Preclinical Models for Developing Therapy for Pediatric Solid Tumors Preclinical Models for Developing Therapy for Pediatric Solid Tumors uses and limitations.
Preclinical Models for Developing Therapy for Pediatric Solid Tumors uses and limitations
